Sort
261,768 grants matching “gene therapy”
India International Center for Excellence in Research
$1,080,177Thomas Nutman · National Institute Of Allergy And Infectious Diseases · ZIA · FY2016 · AI
Epigenetic & Post-Translational Mechanisms of Macrophage Resistance to Mycobacterium tuberculosis During HIV Co-Infection
$1,080,143Thomas R Hawn · University Of Washington · R33 · FY2022 · AI
New targets against tuberculosis
$1,080,104Deborah T Hung · Broad Institute, Inc. · R01 · FY2020 · AI
Center for the Study of Complex Malaria in India
$1,079,922Jane Carlton · New York University · U19 · FY2023 · AI
Immunopathogenesis of Fungal Infections
$1,079,876Michail Lionakis · National Institute Of Allergy And Infectious Diseases · ZIA · FY2015 · AI
City of Hope Lymphoma SPORE
$1,079,832Stephen J Forma · Beckman Research Institute/City Of Hope · P50 · FY2009 · CA
BAY AREA & ANDERSON TEAM AGAINST ACQUIRED RESISTANCE - U54 PROGRAM (BAATAAR-UP)
$1,079,739Trever G Bivona · University Of California, San Francisco · U54 · FY2025 · CA
Eltrombopag for the Treatment of Fanconi Anemia
$1,079,663Andre Larochelle · National Heart, Lung, And Blood Institute · ZIA · FY2025 · HL
Generation of Hematopoietic Stem and Progenitor Cells from iPSCs
$1,079,663Andre Larochelle · National Heart, Lung, And Blood Institute · ZIA · FY2025 · HL
Mechanisms of fenofibrate alone or combined with propranolol in burned patients
$1,079,611David N Herndon · University Of Texas Med Br Galveston · R01 · FY2015 · GM
Develop GABAergic Neuron Protectors for Treating ApoE4-Related Alzheimer's Disease
$1,079,582Robert W. Mahley · Gabaeron, Inc. · R44 · FY2020 · AG
Immunopathogenesis of Fungal Infections
$1,079,497Michail Lionakis · National Institute Of Allergy And Infectious Diseases · ZIA · FY2016 · AI
Identifying therapeutic targets that confer synaptic resilience to Alzheimer's disease
$1,079,457Jeremy H. Herskowitz · University Of Alabama At Birmingham · R01 · FY2021 · AG
Drug Development of GLP-1 receptor agonists
$1,079,455Josephine M Egan · Aging · Z01 · FY2007 · AG
Inflammation and Fibrosis in Pulmonary TB: the INFIN-TB Study
$1,079,424Sara Auld · Emory University · R01 · FY2024 · AI
Targeting centrosomeâmitotic kinases as a novel therapeutic approach against breast cancers in Hispanic/Latinas.
$1,079,390Harold I Saavedra · Ponce School Of Medicine · R01 · FY2025 · CA
Digestive Health Center: Bench to Bedside Research in Pediatric Digestive Diseas
$1,079,350Jorge A. Bezerra · Cincinnati Childrens Hosp Med Ctr · P30 · FY2015 · DK
Digestive Health Center: Bench to Bedside Research in Pediatric Digestive Diseas
$1,079,350Jorge A. Bezerra · Cincinnati Childrens Hosp Med Ctr · P30 · FY2016 · DK
Digestive Health Center: Bench to Bedside Research in Pediatric Digestive Diseas
$1,079,350Jorge A. Bezerra · Cincinnati Childrens Hosp Med Ctr · P30 · FY2014 · DK
Membrane-based vaccine with checkpoint blockade for triple negative breast cancer
$1,079,344Kamal V. Kannan · Metaclipse Therapeutics Corporation · R44 · FY2018 · CA
Identifying vulnerabilities in the long-lived HIV reservoir to accelerate its decay
$1,079,334Ann C Duerr · Fred Hutchinson Cancer Center · R01 · FY2024 · AI
Developing Novel Therapies for High Risk Pediatric Cancers
$1,079,318Javed Khan · Division Of Basic Sciences - Nci · ZIA · FY2025 · CA
Bioinformatics, Machine Learning, Systems Biology of Cancers
$1,079,318Javed Khan · Division Of Basic Sciences - Nci · ZIA · FY2025 · CA
UT M.D. Anderson Cancer Center SPORE in Melanoma
$1,079,303Elizabeth A Grimm · University Of Tx Md Anderson Can Ctr · P50 · FY2009 · CA
Novel Small Molecules For Acute Liver Failure
$1,079,261Prakash Narayan · Angion Biomedica Corporation · R44 · FY2008 · AA